These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1659435)

  • 41. Physiology and pharmacology of neuromuscular transmission, with special reference to the possible consequences of prolonged blockade.
    Bowman WC
    Intensive Care Med; 1993; 19 Suppl 2():S45-53. PubMed ID: 8106678
    [No Abstract]   [Full Text] [Related]  

  • 42. Clinical assessment of neuromuscular transmission.
    Payne JP; Hughes R
    Br J Clin Pharmacol; 1981 Jun; 11(6):537-48. PubMed ID: 6268132
    [No Abstract]   [Full Text] [Related]  

  • 43. Neuromuscular blockade: what was, is and will be.
    Schepens T; Cammu G
    Acta Anaesthesiol Belg; 2014; 65(4):151-9. PubMed ID: 25622380
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical assessment of neuromuscular transmission.
    Viby-Mogensen J
    Br J Anaesth; 1982 Feb; 54(2):209-23. PubMed ID: 6277354
    [No Abstract]   [Full Text] [Related]  

  • 45. Improved neuromuscular blockade using a novel neuromuscular blockade advisory system: a randomized, controlled, clinical trial.
    Gilhuly TJ; Macleod BA; Dumont GA; Bouzane AM; Schwarz SK
    Anesth Analg; 2008 Nov; 107(5):1609-17. PubMed ID: 18931219
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Monitoring neuromuscular blockade in the critically ill.
    Barnette RE; Fish DJ
    Crit Care Med; 1995 Oct; 23(10):1790-1. PubMed ID: 7587250
    [No Abstract]   [Full Text] [Related]  

  • 47. Neuromuscular block: atracurium and vecuronium compared and combined.
    Black TE; Healy TE; Pugh ND; Kay B; Harper NJ; Petts HV; Sivalingham T
    Eur J Anaesthesiol; 1985 Mar; 2(1):29-37. PubMed ID: 2862032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. NMBAs: manage with caution.
    Levins TT
    Nurs Manage; 2002 Aug; 33(8):38-40. PubMed ID: 12163755
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Neuromuscular blocking agents for electroconvulsive therapy: a systematic review.
    Mirzakhani H; Welch CA; Eikermann M; Nozari A
    Acta Anaesthesiol Scand; 2012 Jan; 56(1):3-16. PubMed ID: 22092267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Airway management of the critically ill patient: rapid-sequence intubation.
    Reynolds SF; Heffner J
    Chest; 2005 Apr; 127(4):1397-412. PubMed ID: 15821222
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Investigation of neuromuscular blocking agents at Richter Ltd].
    Kárpáti E; Bíró K; Kukorelli T
    Acta Pharm Hung; 2002; 72(1):37-48. PubMed ID: 12426786
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of neuromuscular blocking drugs in the critically ill patient.
    Coursin DB; Prielipp RC
    Crit Care Clin; 1995 Oct; 11(4):957-81. PubMed ID: 8535988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Interactions of neuromuscular blocking drugs.
    Cammu G
    Acta Anaesthesiol Belg; 2001; 52(4):357-63. PubMed ID: 11799568
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intensive Care Nurses' Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure.
    Frazee EN; Personett HA; Bauer SR; Dzierba AL; Stollings JL; Ryder LP; Elmer JL; Caples SM; Daniels CE
    Am J Crit Care; 2015 Sep; 24(5):431-9. PubMed ID: 26330436
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Management of Neuromuscular Blocking Agents in Critically Ill Patients with Lung Diseases.
    Iavarone IG; Al-Husinat L; Vélez-Páez JL; Robba C; Silva PL; Rocco PRM; Battaglini D
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myoneural actions of Org NC 45.
    Torda TA; Kiloh N
    Br J Anaesth; 1982 Nov; 54(11):1217-21. PubMed ID: 6128014
    [No Abstract]   [Full Text] [Related]  

  • 57. Neuromuscular pharmacology. A clinical update and commentary.
    Lee C; Katz RL
    Br J Anaesth; 1980 Feb; 52(2):173-88. PubMed ID: 6244842
    [No Abstract]   [Full Text] [Related]  

  • 58. Pathophysiological changes of the neuromuscular transmission in the critically ill patient.
    Khuenl-Brady KS
    Acta Anaesthesiol Scand Suppl; 1997; 111():108. PubMed ID: 9420975
    [No Abstract]   [Full Text] [Related]  

  • 59. Skin reactions to intradermal neuromuscular blocking agent injections: a randomized multicenter trial in healthy volunteers.
    Mertes PM; Moneret-Vautrin DA; Leynadier F; Laxenaire MC
    Anesthesiology; 2007 Aug; 107(2):245-52. PubMed ID: 17667568
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A comparison of the neuromuscular blocking and vagolytic effects of ORG NC45 and pancuronium.
    Son SL; Waud BE; Waud DR
    Anesthesiology; 1981 Jul; 55(1):12-8. PubMed ID: 6113793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.